Literature DB >> 2016798

Metastatic properties of the human prostatic cell line, PPC-1, in athymic nude mice.

A R Brothman1, P C Wilkins, E W Sales, K D Somers.   

Abstract

Limitation in the number of human prostatic cell lines has created a gap in knowledge regarding the in-vivo progression of this common cancer. The recently isolated primary prostatic carcinoma cell line, PPC-1, has been shown to be tumorigenic in athymic nude mice. These cells are now shown to form metastases to secondary sites in 10 of 12 animals in this initial study. Metastases were localized to lung and lymph nodes, and the tumor histology closely resembled that of the undifferentiated, rapidly dividing primary tumors. This is the first report describing the metastatic properties of a primary prostatic cancer cell line. PPC-1 cells are therefore likely to represent a good model system for the study of human prostate cancer progression.

Entities:  

Mesh:

Year:  1991        PMID: 2016798     DOI: 10.1016/s0022-5347(17)38540-3

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

1.  The NLR-related protein NWD1 is associated with prostate cancer and modulates androgen receptor signaling.

Authors:  Ricardo G Correa; Maryla Krajewska; Carl F Ware; Motti Gerlic; John C Reed
Journal:  Oncotarget       Date:  2014-03-30

2.  Acid ceramidase promotes nuclear export of PTEN through sphingosine 1-phosphate mediated Akt signaling.

Authors:  Thomas H Beckham; Joseph C Cheng; Ping Lu; S Tucker Marrison; James S Norris; Xiang Liu
Journal:  PLoS One       Date:  2013-10-01       Impact factor: 3.240

3.  Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer.

Authors:  Hiroshi Fukuhara; Masami Kuramochi; Takeshi Fukami; Kohtaro Kasahara; Mutsuo Furuhata; Takahiro Nobukuni; Tomoko Maruyama; Kana Isogai; Takao Sekiya; Taro Shuin; Tadaichi Kitamura; Roger H Reeves; Yoshinori Murakami
Journal:  Jpn J Cancer Res       Date:  2002-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.